Th1 and Th2 Immune Response in Chronic Hepatitis B Patients during a Long-Term Treatment with Adefovir Dipivoxil

• Main Authors: Yanfang Jiang (Author), Zhenhua Ma (Author), Guijie Xin (Author), Hongqing Yan (Author), Wanyu Li (Author), Huining Xu (Author), Chunhai Hao (Author), Junqi Niu (Author), Pingwei Zhao (Author)
• Formato: Libro
• Publicado: Hindawi Limited, 2010-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Adefovir dipivoxil treatment has significantly improved the outcome of chronic hepatitis B virus (HBV) infection. However, it remains largely unknown how immune system responds to the treatment. Chronic HBV patients were treated with adefovir dipivoxil and examined for serum HBV DNA loads, cytokines...